Rising Incidence Of Fetal Chromosomal Abnormalities Fuels Growth In The Carrier Screening Market: Powering Innovation and Expansion in the Global Carrier Screening Market by 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Carrier Screening Market Through 2025?
Recent years have witnessed considerable expansion in the realm of carrier screening. Projected figures indicate a step up from $2.72 billion in 2024 to $3.16 billion by 2025, signifying a robust compound annual growth rate (CAGR) of 16.2%. This upward trajectory during the past period stems from several key factors: heightened public consciousness regarding genetic disorders, the trend of increasing maternal age, greater knowledge surrounding family planning and pregnancy management, proactive measures aimed at averting hereditary illnesses, governmental and institutional health campaigns, coupled with a heightened concentration on conditions passed down through families.

What's the Projected Size of the Global Carrier Screening Market by 2029?
Anticipation points toward substantial expansion within the carrier screening sector over the immediate future, with projections indicating the market will reach a valuation of $5.72 billion by the year 2029, achieving a compound annual growth rate (CAGR) of 16.0%. This projected rise throughout the forecast duration is fundamentally fueled by several key drivers, such as progress in the field of precision medicine, the broadening scope of testing panels available, increased consumer engagement with genomics and direct testing avenues, a heightened concentration on identifying seldom-seen diseases, backing from governmental bodies and insurers, and the incorporation of pharmacogenomics. During this same period, several significant trends are expected to shape the landscape, including ongoing development in genetic testing methodologies, greater assimilation with established prenatal screening processes, a discernible upward trend in the adoption of customized medical care, expansion of services related to genetic counseling and patient education, and ongoing navigation of ethical and legal complexities.

View the full report here:
https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

Top Growth Drivers in the Carrier Screening Industry: What's Accelerating the Market?
Anticipated escalation in the incidence of fetal chromosomal anomalies and hereditary conditions is predicted to fuel the expansion of the market dedicated to carrier screening in the future. Abnormalities in fetal chromosomes describe a condition where the developing fetus possesses an irregular count of chromosomes or an unusual amount of genetic material within a single chromosome. The purpose of conducting prenatal screening for these chromosomal irregularities is to deliver a precise evaluation of the potential risk that a patient is carrying an unborn child affected by such a disorder. To illustrate this, mortality statistics reported by the World Health Organization, a worldwide health body headquartered in Switzerland, indicated that in February 2022, birth defects resulted in the deaths of 240,000 babies within their first four weeks of life annually. Furthermore, an estimated 170,000 children aged between one month and five years succumb to death yearly due to these same birth defects. Adding to this data, information presented by a United Nations Government publication in March 2022 suggested that Down syndrome is thought to impact approximately one in every 1,000 to 1,100 live births across the globe, leading to between 3,000 and 5,000 children being born with this specific chromosomal irregularity each year. Consequently, the rising frequency of both fetal chromosomal problems and genetic diseases serves as the primary impetus behind the market growth for carrier screening.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp

What Trends Will Shape the Carrier Screening Market Through 2029 and Beyond?
Key players within the carrier screening sphere are concentrating on innovations in their offerings, exemplified by the introduction of comprehensive screening test panels, as a strategy to maintain their competitive footing. These diagnostic assessments involve procedures conducted on people who show no manifest signs of a specific ailment or disorder. To illustrate, in the month of June 2023, Blueprint Genetics, a firm situated in Finland renowned for its expertise in genetic analysis and laboratory services, released a novel product line termed the Screening Tests family. This set of assays is tailored for distinct scenarios, including expectant mothers, those planning families, and general wellness evaluations for apparently healthy persons, with the underlying goal of detecting potential predispositions to conditions, thus furnishing individuals with the necessary knowledge to make judicious choices about reproductive decisions and overall health. Blueprint Genetics intends to deliver practical insights that facilitate proactive steps stemming from the myriad of available pathways, highlighting their dedication to aiding individuals in executing well-considered choices concerning their prospective health trajectory.

What Are the Main Segments in the Carrier Screening Market?
The carrier screeningmarket covered in this report is segmented -

1) By Type: Expanded Carrier Screening; Targeted Disease Carrier Screening
2) By Medical Condition: Pulmonary Conditions; Hematological Conditions; Neurological Conditions; Other Medical Conditions
3) By Technology: DNA Sequencing; Polymerase Chain Reaction; Microarrays; Other Technologies
4) By End User: Hospitals; Reference Laboratories; Physician Offices And Clinics; Other End Users

Subsegments:
1) By Expanded Carrier Screening: Whole Exome Sequencing (WES); Next-Generation Sequencing (NGS) Panels; Comprehensive Carrier Screening Tests
2) By Targeted Disease Carrier Screening: Single Gene Tests; Disease-Specific Panels; Ethnic Or Population-Specific Screening Tests

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7952&type=smp

Which Top Companies are Driving Growth in the Carrier Screening Market?
Major companies operating in the carrier screening market are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.

Which Regions Will Dominate the Carrier Screening Market Through 2029?
North America was the largest region in the carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7952

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.